secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quanterix Corp (QTRX)
CIK:        0001503274
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0001503274-25-000080
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quanterix commits to workforce reduction targeting $18M annual savings post-Akoya integration
--------------------------------------------------------------------------------

- Termination plan committed July 18, 2025, to reduce operating costs and preserve cash.
- Annualized cash savings expected ~$18.0 million from headcount reductions, substantially completed in Q3 2025.
- Severance expenses of ~$2.5 million, all cash expenditures in 2025.
- Integration plan to realize synergies from acquisition of Akoya Biosciences, Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503274/000150327425000080/0001503274-25-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503274/000150327425000080/qtrx-20250718.htm
  HTML page:      https://secwatch.observer/filing/0001503274-25-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer